Clinical Trials Browser

Phase EARLY_PHASE1 × Carcinoma, Non-Small-Cell Lung × aldesleukin × Clear all

NCT05493566 2026-02-12

Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer

Phase EARLY_PHASE1 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03224871 2020-04-07

UCDCC#269: A Pilot Study of Interlesional IL-2 and RT in Patients With NSCLC.

Phase EARLY_PHASE1 Completed

Carcinoma, Non-Small-Cell Lung